Illimis Therapeutics

Seoul, South Korea · Founded 2021 · Privately Held (backing)

Developer of protein-based therapeutics designed for the treatment of intractable neurodegenerative diseases. Illimis Therapeutics is based in Seoul, South Korea and was founded in 2021. It has raised $64.3 million.

Last price · $/share

—

Implied valuation

—

Total raised

$64.3M

Last round

—

How much has Illimis Therapeutics raised?

$64.3Macross 0 recorded rounds

Free account

More of Illimis Therapeutics with a free account

·The complete investor list: 27 names
·Watch Illimis Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Illimis Therapeutics investors

27 investors are on record for Illimis Therapeutics, including Tech Incubator Program for Startup, Korea Development Bank, IMM Investment and Hana Ventures. By type, the record holds 8 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like Illimis Therapeutics?

27 investors have backed Illimis Therapeutics.

See all 27 investors →

Frequently asked about Illimis Therapeutics

How much has Illimis Therapeutics raised?: Illimis Therapeutics has raised $64.3M in total across 0 recorded funding rounds.